Login / Signup

Efficacy and safety of sublingual immunotherapy using house dust mite tablet for 1-4 years old children with perennial allergic rhinitis.

Koki SasamotoKen-Ichi NagakuraTomoyuki AsaumiNaoko FusayasuKatsuyo Ohashi-DoiNoriyuki YanagidaSakura SatoMotohiro Ebisawa
Published in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2024)
This pilot study demonstrated the efficacy, safety, and immunomodulatory effects of HDM SLIT-tablet in preschoolers with AR.
Keyphrases
  • allergic rhinitis
  • young adults
  • health risk
  • health risk assessment
  • human health
  • polycyclic aromatic hydrocarbons
  • risk assessment